{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:14:41Z","timestamp":1792149281881,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pelotonia Institute of Immuno-Oncology"},{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["F30CA250244"],"award-info":[{"award-number":["F30CA250244"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41375-025-02829-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:22:28Z","timestamp":1766402548000},"page":"325-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemia"],"prefix":"10.1038","volume":"40","author":[{"given":"Thanh Thanh T.","family":"Dinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7108-9765","authenticated-orcid":false,"given":"Matthew R.","family":"Lordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-585X","authenticated-orcid":false,"given":"Chinmayee","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Shilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Altynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ruesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6004-0740","authenticated-orcid":false,"given":"Parker","family":"Kronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Jeremy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karilyn T.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8392-9970","authenticated-orcid":false,"given":"Adrienne M.","family":"Dorrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon G.","family":"Freud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7397-7653","authenticated-orcid":false,"given":"Bethany L.","family":"Mundy- Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2829_CR1","unstructured":"SEER Cancer Statistics Review. 1975-2019. https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"key":"2829_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"2829_CR3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097\u2013100.","journal-title":"Science"},{"key":"2829_CR4","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1172\/JCI85413","volume":"126","author":"BL Mundy-Bosse","year":"2016","unstructured":"Mundy-Bosse BL, Scoville SD, Chen L, McConnell K, Mao HC, Ahmed EH, et al. MicroRNA-29b mediates altered innate immune development in acute leukemia. J Clin Invest. 2016;126:4404\u201316.","journal-title":"J Clin Invest"},{"key":"2829_CR5","doi-asserted-by":"crossref","unstructured":"Chretien AS, Fauriat C, Orlanducci F, Galseran C, Rey J, Borg GB, et al. Natural killer defective maturation is associated with adverse clinical outcome in patients with acute myeloid leukemia. Front Immunol. 2017;8:573.","DOI":"10.3389\/fimmu.2017.00573"},{"key":"2829_CR6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.4049\/jimmunol.2100023","volume":"207","author":"MR Lordo","year":"2021","unstructured":"Lordo MR, Wu KG, Altynova E, Shilo N, Kronen P, Nalin AP, et al. Acute myeloid leukemia alters group 1 innate lymphoid cell differentiation from a common precursor. J Immunol. 2021;207:1672\u201382.","journal-title":"J Immunol"},{"key":"2829_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3389\/fimmu.2017.01909","volume":"8","author":"S Li","year":"2017","unstructured":"Li S, Bostick JW, Zhou L. Regulation of innate lymphoid cells by aryl hydrocarbon receptor. Front Immunol. 2017;8:1909.","journal-title":"Front Immunol"},{"key":"2829_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/pr.113.007823","volume":"65","author":"FJ Quintana","year":"2013","unstructured":"Quintana FJ, Sherr DH. Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev. 2013;65:1148\u201361.","journal-title":"Pharmacol Rev"},{"key":"2829_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","volume":"23","author":"N Jacquelot","year":"2022","unstructured":"Jacquelot N, Seillet C, Vivier E, Belz GT. Innate lymphoid cells and cancer. Nat Immunol. 2022;23:371\u20139.","journal-title":"Nat Immunol"},{"key":"2829_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","volume":"568","author":"L Zhou","year":"2019","unstructured":"Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature. 2019;568:405\u20139.","journal-title":"Nature"},{"key":"2829_CR11","doi-asserted-by":"crossref","unstructured":"Horn V, Sonnenberg GF. Group 3 innate lymphoid cells in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2024;21:428\u201343.","DOI":"10.1038\/s41575-024-00906-3"},{"key":"2829_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/imm.12697","volume":"150","author":"F Melo-Gonzalez","year":"2017","unstructured":"Melo-Gonzalez F, Hepworth MR. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Immunology. 2017;150:265\u201375.","journal-title":"Immunology"},{"key":"2829_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174:1054\u201366.","journal-title":"Cell"},{"key":"2829_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun. 2015;6:8280.","journal-title":"Nat Commun"},{"key":"2829_CR15","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.3324\/haematol.2014.119602","volume":"100","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli S, Curti A, Lecciso M, Salome B, Riether C, Ochsenbein A, et al. CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis. Haematologica. 2015;100:e257\u201360.","journal-title":"Haematologica"},{"key":"2829_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+CD127+ natural killer-like cells. Nat Immunol. 2009;10:66\u201374.","journal-title":"Nat Immunol"},{"key":"2829_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457:722\u20135.","journal-title":"Nature"},{"key":"2829_CR18","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1182\/blood-2008-12-192443","volume":"113","author":"T Hughes","year":"2009","unstructured":"Hughes T, Becknell B, McClory S, Briercheck E, Freud AG, Zhang X, et al. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood. 2009;113:4008\u201310.","journal-title":"Blood"},{"key":"2829_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145\u20139.","journal-title":"Nat Rev Immunol"},{"key":"2829_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.immuni.2018.08.010","volume":"49","author":"L Chen","year":"2018","unstructured":"Chen L, Youssef Y, Robinson C, Ernst GF, Carson MY, Young KA, et al. CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway. Immunity. 2018;49:464\u201376.e464.","journal-title":"Immunity"},{"key":"2829_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell. 2017;168:1086\u2013100.e1010.","journal-title":"Cell"},{"key":"2829_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12094-019-02160-5","volume":"22","author":"X Xuan","year":"2020","unstructured":"Xuan X, Zhou J, Tian Z, Lin Y, Song J, Ruan Z, et al. ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22\/AKT signaling. Clin Transl Oncol. 2020;22:563\u201375.","journal-title":"Clin Transl Oncol"},{"key":"2829_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1182\/blood-2012-03-415067","volume":"120","author":"NA Zorko","year":"2012","unstructured":"Zorko NA, Bernot KM, Whitman SP, Siebenaler RF, Ahmed EH, Marcucci GG, et al. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias. Blood. 2012;120:1130\u20136.","journal-title":"Blood"},{"key":"2829_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","volume":"154","author":"M Collin","year":"2018","unstructured":"Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154:3\u201320.","journal-title":"Immunology"},{"key":"2829_CR25","doi-asserted-by":"crossref","unstructured":"Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356:eaah4573.","DOI":"10.1126\/science.aah4573"},{"key":"2829_CR26","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","volume":"179","author":"CC Brown","year":"2019","unstructured":"Brown CC, Gudjonson H, Pritykin Y, Deep D, Lavallee VP, Mendoza A, et al. Transcriptional basis of mouse and human dendritic cell heterogeneity. Cell. 2019;179:846\u201363.e824.","journal-title":"Cell"},{"key":"2829_CR27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.immuni.2020.05.005","volume":"52","author":"SL Nutt","year":"2020","unstructured":"Nutt SL, Chopin M. Transcriptional networks driving dendritic cell differentiation and function. Immunity. 2020;52:942\u201356.","journal-title":"Immunity"},{"key":"2829_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27232-5","volume":"12","author":"RD Lee","year":"2021","unstructured":"Lee RD, Munro SA, Knutson TP, LaRue RS, Heltemes-Harris LM, Farrar MA. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation. Nat Commun. 2021;12:6843.","journal-title":"Nat Commun"},{"key":"2829_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04934-4","volume":"609","author":"W Zhou","year":"2022","unstructured":"Zhou W, Zhou L, Zhou J, Bank JRILC, Chu C, Zhang C, et al. ZBTB46 defines and regulates ILC3s that protect the intestine. Nature. 2022;609:159\u201365.","journal-title":"Nature"},{"key":"2829_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TS Heng","year":"2008","unstructured":"Heng TS, Painter MW. Immunological Genome Project C. The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol. 2008;9:1091\u20134.","journal-title":"Nat Immunol"},{"key":"2829_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41422-020-00445-x","volume":"31","author":"L Mazzurana","year":"2021","unstructured":"Mazzurana L, Czarnewski P, Jonsson V, Wigge L, Ringner M, Williams TC, et al. Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing. Cell Res. 2021;31:554\u201368.","journal-title":"Cell Res"},{"key":"2829_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41590-022-01284-1","volume":"23","author":"A Jarade","year":"2022","unstructured":"Jarade A, Garcia Z, Marie S, Demera A, Prinz I, Bousso P, et al. Inflammation triggers ILC3 patrolling of the intestinal barrier. Nat Immunol. 2022;23:1317\u201323.","journal-title":"Nat Immunol"},{"key":"2829_CR33","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1182\/blood-2018-03-838474","volume":"132","author":"SD Scoville","year":"2018","unstructured":"Scoville SD, Nalin AP, Chen L, Chen L, Zhang MH, McConnell K, et al. Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood. 2018;132:1792\u2013804.","journal-title":"Blood"},{"key":"2829_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu J, Heller JJ, Guo X, Chen ZM, Fish K, Fu YX, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity. 2012;36:92\u2013104.","journal-title":"Immunity"},{"key":"2829_CR35","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.immuni.2021.07.019","volume":"54","author":"DC Hernandez","year":"2021","unstructured":"Hernandez DC, Juelke K, Muller NC, Durek P, Ugursu B, Mashreghi MF, et al. An in vitro platform supports generation of human innate lymphoid cells from CD34(+) hematopoietic progenitors that recapitulate ex vivo identity. Immunity. 2021;54:2417\u201332.e2415.","journal-title":"Immunity"},{"key":"2829_CR36","volume":"14","author":"S Verma","year":"2022","unstructured":"Verma S, Singh A, Yadav G, Kushwaha R, Ali W, Verma SP, et al. Serum tumor necrosis factor-alpha levels in acute leukemia and its prognostic significance. Cureus. 2022;14:e24835.","journal-title":"Cureus"},{"key":"2829_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1172\/JCI68101","volume":"124","author":"Y Kagoya","year":"2014","unstructured":"Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S, et al. Positive feedback between NF-kappaB and TNF-alpha promotes leukemia-initiating cell capacity. J Clin Invest. 2014;124:528\u201342.","journal-title":"J Clin Invest"},{"key":"2829_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood-2002-06-1890","volume":"102","author":"S Faderl","year":"2003","unstructured":"Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M, Estrov Z. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood. 2003;102:630\u20137.","journal-title":"Blood"},{"key":"2829_CR39","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1021\/acs.jmedchem.0c00377","volume":"63","author":"W Sun","year":"2020","unstructured":"Sun W, Wu Y, Zheng M, Yang Y, Liu Y, Wu C, et al. Discovery of an orally active small-molecule tumor necrosis factor-alpha inhibitor. J Med Chem. 2020;63:8146\u201356.","journal-title":"J Med Chem"},{"key":"2829_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.2830","volume":"15","author":"G Magri","year":"2014","unstructured":"Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354\u201364.","journal-title":"Nat Immunol"},{"key":"2829_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"2829_CR42","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood.2024025409","volume":"144","author":"H Dohner","year":"2024","unstructured":"Dohner H, DiNardo CD, Appelbaum FR, Craddock C, Dombret H, Ebert BL, et al. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood. 2024;144:2169\u201373.","journal-title":"Blood"},{"key":"2829_CR43","doi-asserted-by":"crossref","unstructured":"Zeng BN, Shi SN, Ashworth G, Dong CJ, Liu J, Xing FY. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis. 2019;10:315.","DOI":"10.1038\/s41419-019-1540-2"},{"key":"2829_CR44","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20122308","volume":"210","author":"S Kirchberger","year":"2013","unstructured":"Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013;210:917\u201331.","journal-title":"J Exp Med"},{"key":"2829_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41590-021-01120-y","volume":"23","author":"M Bruchard","year":"2022","unstructured":"Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, et al. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nat Immunol. 2022;23:262\u201374.","journal-title":"Nat Immunol"},{"key":"2829_CR46","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ni.1947","volume":"11","author":"M Eisenring","year":"2010","unstructured":"Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol. 2010;11:1030\u20138.","journal-title":"Nat Immunol"},{"key":"2829_CR47","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.immuni.2013.05.013","volume":"38","author":"T Glatzer","year":"2013","unstructured":"Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity. 2013;38:1223\u201335.","journal-title":"Immunity"},{"key":"2829_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1540-2","volume":"10","author":"B Zeng","year":"2019","unstructured":"Zeng B, Shi S, Ashworth G, Dong C, Liu J, Xing F. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis. 2019;10:315.","journal-title":"Cell Death Dis"},{"key":"2829_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add6137","volume":"15","author":"HJ Paust","year":"2023","unstructured":"Paust HJ, Song N, De Feo D, Asada N, Tuzlak S, Zhao Y, et al. CD4(+) T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12. Sci Transl Med. 2023;15:eadd6137.","journal-title":"Sci Transl Med"},{"key":"2829_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0145-2126(98)00024-1","volume":"22","author":"XZ Gao","year":"1998","unstructured":"Gao XZ, Bi S, Copra H, Devemy E, Venugopal P, Li B, et al. Cytokine gene activity in AML cells in vivo in patients. Leuk Res. 1998;22:429\u201338.","journal-title":"Leuk Res"},{"key":"2829_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","volume":"100","author":"I Ushach","year":"2016","unstructured":"Ushach I, Zlotnik A. Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J Leukoc Biol. 2016;100:481\u20139.","journal-title":"J Leukoc Biol"},{"key":"2829_CR52","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1158\/0008-5472.CAN-17-3026","volume":"79","author":"Al Sayed","year":"2019","unstructured":"Al Sayed, Amrein MF, Buhrer MA, Huguenin AL ED, Radpour R, Riether C, et al. T-cell-secreted TNFalpha induces emergency myelopoiesis and myeloid-derived suppressor cell differentiation in cancer. Cancer Res. 2019;79:346\u201359.","journal-title":"Cancer Res"},{"key":"2829_CR53","doi-asserted-by":"crossref","unstructured":"Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics. Int J Mol Sci. 2021;22:2719.","DOI":"10.3390\/ijms22052719"},{"key":"2829_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ni.3484","volume":"17","author":"JK Bando","year":"2016","unstructured":"Bando JK, Colonna M. Innate lymphoid cell function in the context of adaptive immunity. Nat Immunol. 2016;17:783\u20139.","journal-title":"Nat Immunol"},{"key":"2829_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41577-019-0194-8","volume":"19","author":"GF Sonnenberg","year":"2019","unstructured":"Sonnenberg GF, Hepworth MR. Functional interactions between innate lymphoid cells and adaptive immunity. Nat Rev Immunol. 2019;19:599\u2013613.","journal-title":"Nat Rev Immunol"},{"key":"2829_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.dld.2019.11.019","volume":"52","author":"AJ Lucendo","year":"2020","unstructured":"Lucendo AJ, Roncero O, Serrano-Duenas MT, Hervias D, Alcazar LM, Miriam Ruiz P, et al. Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease. Dig Liver Dis. 2020;52:400\u20137.","journal-title":"Dig Liver Dis"},{"key":"2829_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ajh.20926","volume":"82","author":"B Nair","year":"2007","unstructured":"Nair B, Raval G, Mehta P. TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature. Am J Hematol. 2007;82:1022\u20134.","journal-title":"Am J Hematol"},{"key":"2829_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/14737140.2.3.277","volume":"2","author":"AM Tsimberidou","year":"2002","unstructured":"Tsimberidou AM, Giles FJ. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies. Expert Rev Anticancer Ther. 2002;2:277\u201386.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2829_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/10428190400027829","volume":"46","author":"R Stasi","year":"2005","unstructured":"Stasi R, Amadori S, Newland AC, Provan D. Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes. Leuk Lymphoma. 2005;46:509\u201316.","journal-title":"Leuk Lymphoma"},{"key":"2829_CR60","doi-asserted-by":"crossref","unstructured":"Scoville SD, Keller KA, Cheng S, Zhang M, Zhang XL, Caligiuri MA, et al. Rapid column-free enrichment of mononuclear cells from solid tissues. Sci Rep. 2015;5:12490.","DOI":"10.1038\/srep12490"},{"key":"2829_CR61","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.4049\/jimmunol.2000434","volume":"205","author":"AP Nalin","year":"2020","unstructured":"Nalin AP, Kowalski JJ, Sprague AC, Schumacher BK, Gerhardt AG, Youssef Y, et al. Notch regulates innate lymphoid cell plasticity during human NK cell development. J Immunol. 2020;205:2679\u201393.","journal-title":"J Immunol"},{"key":"2829_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","volume":"16","author":"AG Freud","year":"2016","unstructured":"Freud AG, Keller KA, Scoville SD, Mundy-Bosse BL, Cheng S, Youssef Y, et al. NKp80 defines a critical step during human natural killer cell development. Cell Rep. 2016;16:379\u201391.","journal-title":"Cell Rep"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02829-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:03:41Z","timestamp":1770278621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02829-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2829"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02829-7","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}